| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8459619 | Radiotherapy and Oncology | 2014 | 7 Pages |
Abstract
Surgery, especially R0/R1 resection, seemed as the gold standard for treatment of biliary tract cancer including RT, even in the highly heterogeneous population obtained from the multicenter retrospective study. The possibility was shown that CRT yielded better survival benefit especially for n1 patients. We recommend that future prospective trials include an arm of adjuvant CRT at least for n1 and possibly R0/R1 patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Yasuo Yoshioka, Kazuhiko Ogawa, Hirobumi Oikawa, Hiroshi Onishi, Nobue Uchida, Toshiya Maebayashi, Naoto Kanesaka, Tetsuro Tamamoto, Hirofumi Asakura, Takashi Kosugi, Kazuo Hatano, Michio Yoshimura, Kazunari Yamada, Sunao Tokumaru, Kenji Sekiguchi,